Literature DB >> 32842168

Daratumumab rapidly reduces high-titre factor VIII inhibitors in haemophilia A patients during life-threatening haemorrhages.

Chatphatai Moonla1,2, Noppacharn Uaprasert1,2, Phandee Watanaboonyongcharoen2,3, Mukmanee Meesanun1,2, Autcharaporn Sukperm1,2, Ratchaneekorn Jantasing1,2, Saruta Faknuam4, Chantiya Chanswangphuwana1,2, Chantana Polprasert1,2, Pimpayao Sodsai5, Benjaporn Akkawat1,2, Nattiya Hirankarn5, Udomsak Bunworasate1,2, Ponlapat Rojnuckarin1,2.   

Abstract

Entities:  

Year:  2020        PMID: 32842168     DOI: 10.1111/hae.14118

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  1 in total

1.  Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Thiti Asawapanumas; Chantiya Chanswangphuwana; Phandee Watanaboonyongcharoen; Ponlapat Rojnuckarin; Udomsak Bunworasate
Journal:  Leuk Res Rep       Date:  2022-04-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.